314 related articles for article (PubMed ID: 15884108)
1. Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma.
Qin HX; Nan KJ; Yang G; Jing Z; Ruan ZP; Li CL; Xu R; Guo H; Sui CG; Wei YC
World J Gastroenterol; 2005 May; 11(18):2709-13. PubMed ID: 15884108
[TBL] [Abstract][Full Text] [Related]
2. Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma.
Jing Z; Nan KJ; Hu ML
World J Gastroenterol; 2005 Apr; 11(13):1910-6. PubMed ID: 15800979
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].
Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386
[TBL] [Abstract][Full Text] [Related]
4. Expression of p57(kip2) and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma.
Nan KJ; Guo H; Ruan ZP; Jing Z; Liu SX
World J Gastroenterol; 2005 Feb; 11(8):1237-40. PubMed ID: 15754413
[TBL] [Abstract][Full Text] [Related]
5. P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection.
Qin LX; Tang ZY; Ma ZC; Wu ZQ; Zhou XD; Ye QH; Ji Y; Huang LW; Jia HL; Sun HC; Wang L
World J Gastroenterol; 2002 Jun; 8(3):459-63. PubMed ID: 12046070
[TBL] [Abstract][Full Text] [Related]
6. Effects of p53 on apoptosis and proliferation of hepatocellular carcinoma cells treated with transcatheter arterial chemoembolization.
Xiao EH; Li JQ; Huang JF
World J Gastroenterol; 2004 Jan; 10(2):190-4. PubMed ID: 14716820
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
8. [Expression of human telomerase reverse transcriptase gene in HCC does not depend on proliferating cell nuclear antigen and P53].
Zhang D; Li KZ; Dou KF; Gao ZQ; Song ZS; Zhao QC; Fu YC
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):721-2. PubMed ID: 15555445
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection.
Hu TH; Wang CC; Huang CC; Chen CL; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Tai MH
Oncol Rep; 2007 Dec; 18(6):1417-26. PubMed ID: 17982625
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma.
Stroescu C; Dragnea A; Ivanov B; Pechianu C; Herlea V; Sgarbura O; Popescu A; Popescu I
J Gastrointestin Liver Dis; 2008 Dec; 17(4):411-7. PubMed ID: 19104702
[TBL] [Abstract][Full Text] [Related]
11. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
[TBL] [Abstract][Full Text] [Related]
13. Decreased levels of nitric oxide production and nitric oxide synthase-2 expression are associated with the development and metastasis of hepatocellular carcinoma.
Zhou L; Wang Y; Tian DA; Yang J; Yang YZ
Mol Med Rep; 2012 Dec; 6(6):1261-6. PubMed ID: 23007408
[TBL] [Abstract][Full Text] [Related]
14. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
15. Imbalance between cell proliferation and cellular DNA fragmentation in hepatocellular carcinoma.
Wu PC; Lau VK; Fang JW; Lai VC; Lai CL; Lau JY
Liver; 1999 Oct; 19(5):444-51. PubMed ID: 10533805
[TBL] [Abstract][Full Text] [Related]
16. Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis.
Nan KJ; Ruan ZP; Jing Z; Qin HX; Wang HY; Guo H; Xu R
World J Gastroenterol; 2005 Jan; 11(2):228-31. PubMed ID: 15633221
[TBL] [Abstract][Full Text] [Related]
17. The clinical utility of the proliferating cell nuclear antigen expression in patients with hepatocellular carcinoma.
Ma S; Yang J; Li J; Song J
Tumour Biol; 2016 Jun; 37(6):7405-12. PubMed ID: 26676639
[TBL] [Abstract][Full Text] [Related]
18. Expressions of nucleoside diphosphate kinase (nm23) in tumor tissues are related with metastasis and length of survival of patients with hepatocellular carcinoma.
An R; Meng J; Shi Q; Dai XX; Chen JH; Lei YJ; Shan B; Gao C; Chu YL; Dong XP
Biomed Environ Sci; 2010 Aug; 23(4):267-72. PubMed ID: 20934113
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of tumor suppressor p33(ING1b) and its synergy with p53 gene in hepatocellular carcinoma.
Zhu Z; Lin J; Qu JH; Feitelson MA; Ni CR; Li FM; Zhu MH
World J Gastroenterol; 2005 Apr; 11(13):1903-9. PubMed ID: 15800978
[TBL] [Abstract][Full Text] [Related]
20. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]